outperform price
provid calm jitteri environ
put pall earn visibl group
background bax guid msd organ provid
sens calm normalci investor revenu
front see elev demand renal iv
solut see declin advanc surgeri
procedur volum declin manag note
ok suppli chain front worsen situat
could chang given model low singl
digit organ revenue growth
deceler margin front increas invest
ensur suppli like limit omx model modest
expans yield msd ep growth win
environ lastli also provid restat
financi came note expect
convers step go forward lower
pt mainli due market multipl contract
lower ep estimate expect med-tech sector
pressur come month suppli name like
like fare better group
caus us reiter outperform rate share
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
fy guidanc remov light
ep
audit complet
compon sourc itali china strain suppli issu yet
take alloc approach meet demand product
wait aakhi
howev renal continu keep pace ahead new guidanc
instal pump continu
mm distributor purchas ahead flu
cheetah contribut less mm
olimel finomel launch support growth
new product us eu support growth
hospit pharma compound servic driver
gener inject well
anesthesia off-set
cyclo mm
floseal contribut strong
prismax well-receiv us far
 focu still adjac cheaper make equal amount sens
repo bn full year
electron sourc eu china
iv bag us made us local-ish mfg
reserv factori made follow hurrican maria
product line begin switch revaclear theranova
capit pattern slow despit servic rep go dialysi center
focu stock order ensur access care
similar ration realli
fda like slow approv process
valuat may bring asset purchas rang
convers new normal compani focus
valuat methodolog base mix discount cash flow analysi rel valuat multipl
increas competit price pressur fluid system fda qualiti issu tax reform uncertainti inabl
articl articl
time dissemin march pm et
analyst jon bristow vijay kumar primarili respons prepar research report attest follow view
opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
